Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04725721 · ClinicalTrials.gov registry record · NA

Testing FIRST in Youth Outpatient Psychotherapy

A NA study of Depression and Anxiety, sponsored by Harvard University.

Recruiting
Registry status
NA
Development phase
212
Enrollment target
2
Study locations

NCT04725721 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Harvard University. The registered enrollment target is 212 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04725721, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Harvard University.

RECRUITING
Registry status
NA
Development phase
212 participants
Enrollment target
2
Study locations

Study Summary

The study will compare the impact FIRST (a transdiagnostic treatment built upon five empirically supported principles of change) versus usual care outpatient psychotherapy on youths' mental health outcomes and a candidate mechanism of change: regulation of negative emotions.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL FIRST

Study Locations (2)

Massachusetts

  • Harvard University - Cambridge

Texas

  • University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2021-09-27
Est. Completion 2026-02
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT04725721

The ClinicalTrials.gov registry entry for NCT04725721 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower). The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04725721 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Texas.

Frequently Asked Questions

What is clinical trial NCT04725721 about?

NCT04725721 is a clinical study titled "Testing FIRST in Youth Outpatient Psychotherapy". The study will compare the impact FIRST (a transdiagnostic treatment built upon five empirically supported principles of change) versus usual care outpatient psychotherapy on youths' mental health outcomes and a candidate mechanism of change: regulation of negative emotions.

What is the current status of trial NCT04725721?

This trial is currently recruiting. It is a NA study. The enrollment target is 212 participants. The study started on 2021-09-27. Estimated completion is 2026-02.

What conditions does trial NCT04725721 study?

This clinical trial studies the following conditions: Depression, Anxiety, Trauma, Behavior Problem.

What interventions are being tested in trial NCT04725721?

The interventions under investigation include: Usual Care (BEHAVIORAL), FIRST (BEHAVIORAL).

Who is sponsoring clinical trial NCT04725721?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04725721 being conducted?

This trial has 2 study locations across Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.